Sotera Health (NASDAQ:SHC) Shares Gap Up to $11.30

Sotera Health (NASDAQ:SHCGet Free Report)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $11.30, but opened at $11.93. Sotera Health shares last traded at $12.17, with a volume of 357,665 shares.

Wall Street Analyst Weigh In

SHC has been the topic of several research analyst reports. Barclays raised their target price on Sotera Health from $17.00 to $19.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 28th. TheStreet raised shares of Sotera Health from a “d” rating to a “c-” rating in a report on Tuesday, February 27th. Royal Bank of Canada restated an “outperform” rating and issued a $20.00 target price on shares of Sotera Health in a report on Monday, March 4th. Jefferies Financial Group raised shares of Sotera Health from a “hold” rating to a “buy” rating and increased their target price for the company from $15.00 to $15.50 in a research report on Monday. Finally, KeyCorp initiated coverage on shares of Sotera Health in a research report on Tuesday, February 6th. They issued a “sector weight” rating for the company. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.38.

View Our Latest Analysis on SHC

Sotera Health Price Performance

The company has a quick ratio of 2.21, a current ratio of 2.42 and a debt-to-equity ratio of 5.16. The firm has a market capitalization of $3.26 billion, a price-to-earnings ratio of 64.06 and a beta of 2.16. The company has a fifty day moving average price of $14.92 and a two-hundred day moving average price of $14.69.

Sotera Health (NASDAQ:SHCGet Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $0.26 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.26. The firm had revenue of $310.24 million during the quarter, compared to analysts’ expectations of $302.17 million. Sotera Health had a net margin of 4.90% and a return on equity of 51.32%. Sotera Health’s quarterly revenue was up 23.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.23 EPS. On average, equities research analysts expect that Sotera Health will post 0.64 EPS for the current fiscal year.

Insider Activity at Sotera Health

In other Sotera Health news, Director Pincus & Co. Warburg sold 16,594,363 shares of the stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.31, for a total transaction of $237,465,334.53. Following the completion of the sale, the director now directly owns 88,822,952 shares of the company’s stock, valued at approximately $1,271,056,443.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Sotera Health news, Director Pincus & Co. Warburg sold 16,594,363 shares of the business’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.31, for a total value of $237,465,334.53. Following the transaction, the director now directly owns 88,822,952 shares of the company’s stock, valued at approximately $1,271,056,443.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michael P. Rutz sold 83,109 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.31, for a total transaction of $1,189,289.79. Following the completion of the sale, the insider now owns 544,409 shares of the company’s stock, valued at approximately $7,790,492.79. The disclosure for this sale can be found here. 65.13% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Sotera Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bleakley Financial Group LLC increased its holdings in shares of Sotera Health by 7.3% in the 2nd quarter. Bleakley Financial Group LLC now owns 12,509 shares of the company’s stock valued at $236,000 after purchasing an additional 851 shares in the last quarter. Sei Investments Co. grew its position in Sotera Health by 2.2% during the fourth quarter. Sei Investments Co. now owns 39,645 shares of the company’s stock worth $330,000 after buying an additional 851 shares during the period. Public Employees Retirement System of Ohio increased its holdings in Sotera Health by 2.1% in the fourth quarter. Public Employees Retirement System of Ohio now owns 50,660 shares of the company’s stock valued at $422,000 after buying an additional 1,062 shares in the last quarter. Lazard Asset Management LLC lifted its position in shares of Sotera Health by 14.0% during the 4th quarter. Lazard Asset Management LLC now owns 9,908 shares of the company’s stock valued at $82,000 after acquiring an additional 1,217 shares during the period. Finally, Victory Capital Management Inc. boosted its stake in shares of Sotera Health by 6.1% during the 4th quarter. Victory Capital Management Inc. now owns 21,635 shares of the company’s stock worth $180,000 after acquiring an additional 1,247 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

About Sotera Health

(Get Free Report)

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

Recommended Stories

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.